These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29352142)

  • 1. FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway.
    Zhao X; Wang X; Li Q; Chen W; Zhang N; Kong Y; Lv J; Cao L; Lin D; Wang X; Xu G; Wu X
    Cell Death Dis; 2018 Jan; 9(2):46. PubMed ID: 29352142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FBXL10/KDM2B scaffolding protein associates with novel polycomb repressive complex-1 to regulate adipogenesis.
    Inagaki T; Iwasaki S; Matsumura Y; Kawamura T; Tanaka T; Abe Y; Yamasaki A; Tsurutani Y; Yoshida A; Chikaoka Y; Nakamura K; Magoori K; Nakaki R; Osborne TF; Fukami K; Aburatani H; Kodama T; Sakai J
    J Biol Chem; 2015 Feb; 290(7):4163-77. PubMed ID: 25533466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.
    Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG
    J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
    Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J
    J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.
    Ueda T; Nagamachi A; Takubo K; Yamasaki N; Matsui H; Kanai A; Nakata Y; Ikeda K; Konuma T; Oda H; Wolff L; Honda Z; Wu X; Helin K; Iwama A; Suda T; Inaba T; Honda H
    Blood; 2015 May; 125(22):3437-46. PubMed ID: 25872778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
    Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
    J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation.
    Wu X; Johansen JV; Helin K
    Mol Cell; 2013 Mar; 49(6):1134-46. PubMed ID: 23395003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.
    Farcas AM; Blackledge NP; Sudbery I; Long HK; McGouran JF; Rose NR; Lee S; Sims D; Cerase A; Sheahan TW; Koseki H; Brockdorff N; Ponting CP; Kessler BM; Klose RJ
    Elife; 2012 Dec; 1():e00205. PubMed ID: 23256043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of histone demethylase Fbxl10 leads to enhanced migration in mouse embryonic fibroblasts.
    Rohde M; Sievers E; Janzer A; Willmann D; Egert A; Schorle H; Schüle R; Kirfel J
    Exp Cell Res; 2016 Nov; 348(2):123-131. PubMed ID: 27646113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephaly.
    Fukuda T; Tokunaga A; Sakamoto R; Yoshida N
    Mol Cell Neurosci; 2011 Mar; 46(3):614-24. PubMed ID: 21220025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.
    Tzatsos A; Paskaleva P; Lymperi S; Contino G; Stoykova S; Chen Z; Wong KK; Bardeesy N
    J Biol Chem; 2011 Sep; 286(38):33061-9. PubMed ID: 21757686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer.
    Yan M; Yang X; Shen R; Wu C; Wang H; Ye Q; Yang P; Zhang L; Chen M; Wan B; Zhang Q; Xia S; Lu X; Shao G; Zhou X; Yu J; Shao Q
    Cell Death Dis; 2018 Nov; 9(11):1123. PubMed ID: 30409964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXL10 protects Polycomb-bound genes from hypermethylation.
    Boulard M; Edwards JR; Bestor TH
    Nat Genet; 2015 May; 47(5):479-85. PubMed ID: 25848754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells.
    Galbiati A; Penzo M; Bacalini MG; Onofrillo C; Guerrieri AN; Garagnani P; Franceschi C; Treré D; Montanaro L
    Oncotarget; 2017 Jun; 8(23):37091-37103. PubMed ID: 28415746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation.
    Han XR; Zha Z; Yuan HX; Feng X; Xia YK; Lei QY; Guan KL; Xiong Y
    Oncogene; 2016 Aug; 35(32):4179-90. PubMed ID: 26725323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis.
    Duan S; Moro L; Qu R; Simoneschi D; Cho H; Jiang S; Zhao H; Chang Q; de Stanchina E; Arbini AA; Pagano M
    Cell Rep; 2021 Oct; 37(3):109870. PubMed ID: 34686346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JMJD3 promotes survival of diffuse large B-cell lymphoma subtypes via distinct mechanisms.
    Zhang Y; Shen L; Stupack DG; Bai N; Xun J; Ren G; Han J; Li L; Luo Y; Xiang R; Tan X
    Oncotarget; 2016 May; 7(20):29387-99. PubMed ID: 27102442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα.
    Yang Y; Li S; Li B; Li Y; Xia K; Aman S; Yang Y; Ahmad B; Zhao B; Wu H
    Cancer Lett; 2021 Apr; 502():108-119. PubMed ID: 33450359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic study of the cellular metabolic regulation of Jhdm1b in tumor cells.
    Yu X; Wang J; Wu J; Shi Y
    Mol Biosyst; 2015 Jul; 11(7):1867-75. PubMed ID: 25877602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth.
    Bujisic B; De Gassart A; Tallant R; Demaria O; Zaffalon L; Chelbi S; Gilliet M; Bertoni F; Martinon F
    Blood; 2017 Apr; 129(17):2420-2428. PubMed ID: 28167662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.